Glycated albumin predicts long-term survival in patients undergoing hemodialysis

Chien Lin Lu, Wen Ya Ma, Yuh Feng Lin, Jia Fwu Shyu, Yuan Hung Wang, Yueh Min Liu, Chia Chao Wu, Kuo Cheng Lu

研究成果: 雜誌貢獻文章同行評審

11 引文 斯高帕斯(Scopus)


Background: In patients with advanced renal dysfunction undergoing maintenance hemodialysis, glycated albumin (GA) levels may be more representative of blood glucose levels than hemoglobin A1C levels. The aim of this study was to determine the predictive power of GA levels on long-term survival in hemodialysis patients. Methods: A total of 176 patients with a mean age of 68.2 years were enrolled. The median duration of follow-up was 51.0 months. Receiver-operating characteristic curve analysis was utilized to determine the optimal cutoff value. We examined the cumulative survival rate by Kaplan-Meier estimates and the influence of known survival factors with the multivariate Cox proportional-hazard regression model. Results: In the whole patient group, cumulative survival in the low GA group was better than in the high GA group (p=0.030), with more prominence in those aged <70 years (p=0.029). In subgroup analysis, both diabetic (DM) and non-DM patients with low GA had a better cumulative survival compared with those with high GA. The risk of mortality increased by 3.0% for each 1% increase in serum GA level in all patients undergoing hemodialysis. Conclusions: In addition to serving as a glycemic control marker, GA levels may be useful for evaluating the risk of death in both DM and non-DM patients on hemodialysis.
頁(從 - 到)395-402
期刊International Journal of Medical Sciences
出版狀態已發佈 - 5月 10 2016

ASJC Scopus subject areas

  • 醫藥 (全部)


深入研究「Glycated albumin predicts long-term survival in patients undergoing hemodialysis」主題。共同形成了獨特的指紋。